What is LOPJLB’s current signal on SPRO?

LOPJLB’s latest quantitative signal on Spero Therapeutics, Inc. (SPRO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is SPRO in?

Spero Therapeutics, Inc. (SPRO) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Spero Therapeutics, Inc. (SPRO) do?

Spero Therapeutics, Inc. is a biopharmaceutical firm in the clinical development stage, primarily focused on discovering, advancing, and commercializing innovative treatments for multi-drug resistant (MDR) bacterial infections and rare diseases within the United States. The company's pipeline includes several key therapeutic candidates: tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-c…